First Shanghai Investments Ltd

Chart & Performance

D1W1MN

P/E

—

P/S

1.67

EPS

—

Div Yield, %

0.00%

Shrs. gr., 5y

2.72%

Rev. gr., 5y

-7.96%

Revenues

313m

-8.57%

Net income

-11m

L-81.94%

CFO

Dividend

Jun 08, 20160.01 HKD/sh

Earnings

May 23, 2025

Profile

First Shanghai Investments Limited, an investment holding company, engages in financial services, property and hotel, medical and healthcare, and direct investment sectors in Hong Kong, the People's Republic of China, and internationally. The company offers securities investment, securities broking, margin financing, corporate finance, underwriting and placements, asset management, wealth management, shares placement, IPO subscription, shares custodian, nominee, financial intermediary, and investment advisory services. It also develops residential, service apartment, commercial office, industrial office, hotel, and recreation resort properties; develops and commercializes therapeutic drugs; and provides container transportation and freight forwarding services. In addition, the company operates a medical center in Central, Hong Kong that provides medical and healthcare services, including imaging, day surgery, endoscopy, and check-up services, as well as medical beauty treatments, and general and specialist consultation services. Further, it provides money lending, nominee, agency, management and secretarial, financial leasing and consultancy, internet financial service system, dental, futures broking, stock broking, insurance broking, and property investment services, as well as operates hotel and golf course. The company was formerly known as Public International Investments Limited and changed its name to First Shanghai Investments Limited in June 1993. First Shanghai Investments Limited was founded in 1964 and is based in Central, Hong Kong.

URL

https://www.firstshanghai.com.hk/zh-hant/

IPO date

Aug 24, 1972

Employees

566

Domiciled in

Incorporated in

Valuation

Order:

Title HKD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title HKD in thousands, except ratios and share amounts	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12	2014‑12
Income
Revenues	312,875 -8.57%	342,183 -35.42%	529,850 15.69%
Cost of revenue	374,621	408,255	616,695
Unusual Expense (Income)
NOPBT	(61,746)	(66,072)	(86,845)
NOPBT Margin
Operating Taxes	15,837	(4,969)	60,660
Tax Rate
NOPAT	(77,583)	(61,103)	(147,505)
Net income	(10,629) -81.94%	(58,844) -60.51%	(148,998) 64.05%
Dividends
Dividend yield
Proceeds from repurchase of equity	66,246	1,863	34,542
BB yield	-35.05%	-0.67%	-11.57%
Debt
Debt current	148,934	166,866	217,652
Long-term debt	94,573	125,195	138,573
Deferred revenue		53,180	42,907
Other long-term liabilities	876	(52,923)	(42,907)
Net debt	(119,375)	19,460	(29,348)
Cash flow
Cash from operating activities	6,012	(66,510)	3,662
CAPEX	(2,834)	(9,369)	(7,364)
Cash from investing activities	114,893	86,713	49,268
Cash from financing activities	(24,942)	(92,353)	(44,907)
FCF	(831,851)	(4,354,039)	4,332,990
Balance
Cash	334,668	241,856	325,485
Long term investments	28,214	30,745	60,088
Excess cash	347,238	255,492	359,080
Stockholders' equity	2,470,307	2,380,013	2,558,791
Invested Capital	2,299,066	2,344,505	2,479,984
ROIC
ROCE
EV
Common stock shares outstanding	1,643,653	1,564,546	1,456,246
Price	0.12 -35.75%	0.18 -12.68%	0.21 -34.92%
Market cap	189,020 -32.51%	280,054 -6.19%	298,530 -34.05%
EV	173,795	362,739	343,030
EBITDA	(19,782)	(21,391)	19,528
EV/EBITDA			17.57
Interest	36,472	15,289	30,179
Interest/NOPBT